Limb loss is frequently associated with postamputation pain that can be challenging to treat and often involves opioids. Advances in the field of neuromodulation has led to development of an intentionally reversible percutaneous peripheral nerve stimulation (PNS) system that has had promising results when treating chronic postamputation pain. PNS may offer sustained pain relief even after the treatment period has ended. Currently, there is no convincing evidence regarding the role of PNS in the acute postoperative period, which may be a critical time to control pain as those with higher pain appear to be at higher risk for developing persistent post-procedural pain. The investigators of this study aim to evaluate the feasibility and effects of PNS in the acute postoperative period and determine the feasibility of completing a randomized controlled treatment outcome study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Average Phantom Limb Pain (PLP) Score
Timeframe: Baseline, Weeks 1-4, Weeks 5-8, and Month 3.
Average Residual Limb Pain (RLP) Score
Timeframe: Baseline, Weeks 1-4, Weeks 5-8, and Month 3
Worst Phantom Limb Pain (PLP) Score
Timeframe: Baseline, Weeks 1-4, 5-8, and Month 3
Worst Residual Limb Pain (RLP) Score
Timeframe: Baseline, Weeks 1-4, Weeks 5-8, and Month 3
Best Phantom Limb Pain (PLP) Score
Timeframe: Baseline, Weeks 1-4, Weeks 5-8, and Month 3
Best Residual Limb Pain (RLP) Score
Timeframe: Baseline, Weeks 1-4, Weeks 5-8, and Month 3